Oxytocin and Social Decision Making in Schizophrenia
Status:
Completed
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
schizophrenia patients and healthy volunteers will be included. Subjects who meet the
inclusion and exclusion criteria for the study will be recruited. After completion of
clinical assessments and neuropsychological assessments, all subjects will undergo two fMRI
scans. In one scan subjects will receive a single dose of intranasal oxytocin and in another
scan, they will receive intranasal saline. The order of administration of oxytocin or saline
will be counterbalanced so that they are not administered in the same order to all subjects.
Subjects will be blind to the drug administered.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Mental Health and Neuro Sciences, India